European Medicines Agency adopts first positive opinion for a medicinal product derived from transgenic biotechnology
London, 02 Jun 2006 The European Medicines Agency has adopted the first positive opinion for a medicinal product derived from transgenic biotechnology. ATryn, from Genzyme Europe, contains...